Safety and Efficacy of NK510 to Treat NSCLC
Safety and Efficacy of NK510 to Treat NSCLC
Recruiting · NCT06097962 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NK510 to Treat NSCLC | Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, neoplasm, non-small cell lung carcinoma, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Early phase 1 | 2026-09-09 | NCT06097962 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Base Therapeutics (Shanghai) Co., Ltd. | 4 |
| Jinling Hospital, China | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jinling hospital, affiliated to Medical school Nanjing University | Nanjing | China | 1 |